Thelium Therapeutics

About:

Thelium Therapeutics is an early-stage preclinical company that develops agents to restore the intestinal barriers in inflammatory diseases.

Website: http://www.theliumtx.com/

Description:

Thelium Therapeutics is an early-stage preclinical company headquartered in San Carlos, California. Investors include RVF, JJDC, 8VC, Sheatree capital.

Total Funding Amount:

$18M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Carlos, California, United States

Founded Date:

2019-01-01

Founders:

Vallen Graham

Number of Employees:

1-10

Last Funding Date:

2022-05-05

IPO Status:

Private

Industries: